RETACRIT 4000 IU Price

Overview

Welcome to Dwaey, specifically on RETACRIT 4000 IU Injection/Solution for page.
This medicine contains an important and useful components, as it consists of Epoetin beta.
RETACRIT 4000 IU is available in the market in concentration 4000 IU/PFS and in the form of Injection/Solution for.

HOSPIRA UK LIMITED is the producer of RETACRIT 4000 IU and it is imported from UK, The most popular alternatives of RETACRIT 4000 IU are listed downward .

Mode Of Action

Epoetin beta stimulates RBC production in the bone marrows which transmits O2 through out the body.

Indication

• Anaemia of chronic renal failure
• Anaemia in zidovudine-treated HIV-infected patients
• Anemia related to non-myeloid malignant disease chemotherapy
• To reduce the need for allogenic blood tranfusion
• Anaemia of prematurity.

Precaution

Hypertension, history of seizure, thrombocytosis, chronic hepatic impairment, ischaemic vascular disease, malignant tumours, epilepsy; recent MI or CVA. Fe deficiency, infection, inflammatory disorders, haemolysis and aluminium intoxication may decrease response to epoetin beta. Regularly monitor platelet counts and serum-potassium concentrations. Control haematocrit levels. Poorly-controlled hypertension: Monitor BP, Hb and electrolytes. Anaemia (eg, megaloblastic or folic acid): Give Fe supplements when needed. Thromobocytosis: monitor platelet count for 1st 8 wk. Lactation. Lactation: not known if excreted in breast milk, use caution

Side Effects

• >10% Hypertension (13%)
• Diarrhea (11%)
• Nasopharyngitis (11%) 1-10% Headache (9%)
• Upper respiratory tract infection (9%)
• Cough (6%)
• Hypotension (5%)
• Urinary tract infection (5%)
• Procedural arteriovenous fistula thrombosis (5%) Frequency Not Defined Coronary artery disease
• Anemia
• Septic shock
• Serious cardiovascular and thromboembolic events
• Seizures
• Immunogenicity related PRCA
• Increased mortality and/or tumor progression in cancer patients
• Increased mortality
• Concomitant termination of other CRF therapy
• Stevens-Johnson syndrome
• Toxic epidermal necrolysis

Contra indication

Uncontrolled hypertension. Neonates: injections containing benzyl alcohol.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks